Statin Use Linked with Lower Mortality after Colorectal Cancer Diagnosis

Share this content:
Cumulative exposure to statins after a diagnosis of colorectal cancer was associated with lower overall mortality.
Cumulative exposure to statins after a diagnosis of colorectal cancer was associated with lower overall mortality.

Cumulative exposure to statins after a diagnosis of colorectal cancer was associated with lower overall mortality, a new study published in the British Journal of Cancer has shown.

For the study, researchers sought to determine whether there is an independent association between metformin, statins, and aspirin with overall mortality after colorectal cancer diagnosis among those taking glucose-lowering drugs.

Previous research has shown that an association exists without adjusting for one another.

Researchers identified 1,043 patients who were prescribed glucose-lowering drugs before receiving a diagnosis of colorectal cancer. Of those, 64% used metformin, 61% used statins, and 47% used aspirin after cancer diagnosis.

RELATED: Statins Linked with Better Lung Cancer Survival

Results showed no independent association between cumulative exposure to metformin or aspirin and overall mortality; however, researchers observed a favorable effect of statin use, which increased with cumulative exposure (HR = 0.93; 95% CI: 0.89, 0.98).

The findings suggest that statins may be beneficial among patients with colorectal cancer taking glucose-lowering drugs for diabetes to improve survival.

Reference

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs